ロード中...
5PSQ-083 Study of the prevalence of immunogenicity in patients treated with anti-tumour necrosis factor monoclonal antibodies
BACKGROUND: The loss of response in patients treated with anti-TNFα monoclonal antibodies is relatively frequent. One of the reasons is the development of immunogenicity, causing treatment failure. PURPOSE: To determine the prevalence of immunogenicity in patients with anti-TNF monoclonal antibodies...
保存先:
| 出版年: | Eur J Hosp Pharm |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Group
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535275/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.437 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|